Suppr超能文献

在单细胞分辨率下观察人肺移植中的缺血再灌注反应。

Ischemia-reperfusion responses in human lung transplants at the single-cell resolution.

机构信息

Latner Thoracic Research Laboratories, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Latner Thoracic Research Laboratories, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada; Department of Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

出版信息

Am J Transplant. 2024 Dec;24(12):2199-2211. doi: 10.1016/j.ajt.2024.08.019. Epub 2024 Aug 26.

Abstract

Ischemia-reperfusion is an unavoidable step of organ transplantation. Development of therapeutics for lung injury during transplantation has proved challenging; understanding lung injury from human data at the single-cell resolution is required to accelerate the development of therapeutics. Donor lung biopsies from 6 human lung transplant cases were collected at the end of cold preservation and 2-hour reperfusion and underwent single-cell RNA sequencing. Donor and recipient origin of cells from the reperfusion timepoint were deconvolved. Gene expression profiles were: (1) compared between each donor cell type between timepoints and (2) compared between donor and recipient cells. Inflammatory responses from donor lung macrophages were found after reperfusion with upregulation of multiple cytokines and chemokines, especially IL-1β and IL-1α. Significant inflammatory responses were found in alveolar epithelial cells (featured by CXCL8) and lung endothelial cells (featured by IL-6 upregulation). Different inflammatory responses were noted between donor and recipient monocytes and CD8+ T cells. The inflammatory signals and differences between donor and recipient cells observed provide insight into the cellular and molecular mechanisms of ischemia-reperfusion induced lung injury. Further investigations may lead to the development of novel targeted therapeutics.

摘要

缺血再灌注是器官移植中不可避免的步骤。开发移植过程中肺损伤的治疗方法一直具有挑战性;需要从单细胞分辨率的人体数据中了解肺损伤,以加速治疗方法的开发。在冷保存结束和再灌注 2 小时时从 6 例人类肺移植病例中收集供体肺活检,并进行单细胞 RNA 测序。对再灌注时间点的供体和受体来源的细胞进行去卷积。基因表达谱:(1) 在每个供体细胞类型之间在时间点之间进行比较和(2) 在供体和受体细胞之间进行比较。在再灌注后,供体肺巨噬细胞中发现了炎症反应,多个细胞因子和趋化因子上调,特别是 IL-1β 和 IL-1α。肺泡上皮细胞(以 CXCL8 为特征)和肺内皮细胞(以 IL-6 上调为特征)中存在明显的炎症反应。供体和受体单核细胞和 CD8+T 细胞之间存在不同的炎症反应。观察到的供体和受体细胞之间的炎症信号和差异提供了对缺血再灌注引起的肺损伤的细胞和分子机制的深入了解。进一步的研究可能会导致新型靶向治疗方法的开发。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验